GENEVA, Sept. 16 -- NERACARE GMBH (Eschenheimer Anlage 2660318 Frankfurt) filed a patent application (PCT/EP2025/056020) for "COMPANION DIAGNOSTIC FOR EARLY-STAGE MELANOMA" on Mar 05, 2025. With publication no. WO/2025/186331, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): STROBEL, Anton (Feichthofstr 7181247 Munich)
Abstract:
The disclosure relates to a companion diagnostic immunohistochemical assay for the selection of early-stage melanoma patients at high risk of relapse and/or death for treatment.
For more info...